APC and neoplasm: Our data showing that ER+ tumours are more likely to be screen-detected than ER− tumours (53% vs. 30%), and our APC model results showing incidence of ER+ tumours greatest for those of screening ages between 65 and 72 years, suggest that some of the increases observed in ER+ tumours are likely to be due to detection of prevalent disease in these older women.